May 27, 2010 — The tumor necrosis factor (TNF)–α inhibitor adalimumab may be helpful as adjunct treatment of sciatica, according to the results of a multicenter, randomized, double-blind, ...
JERSEY CITY, N.J. & INCHEON, Korea--(BUSINESS WIRE)--Organon & Co. (NYSE: OGN) & Samsung Bioepis Co., Ltd. today announced that HADLIMAâ„¢ (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback